Life Molecular Imaging (formerly Piramal Imaging) is now part of the Alliance Medical Group, an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. These combined services allow physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine.

With an ever increasing demand of effective care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity for:
- Earlier detection and better characterization of diseases
- Determining the right therapy at the right dose for a patient (precision medicine)
- Monitoring therapy response

As a global leader in the field of radiopharmaceuticals, Life Molecular Imaging is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology.

Life Molecular Imaging is supporting use of imaging biomarkers in several major therapeutic trials in Alzheimer’s disease.

Imprint:
Life Molecular Imaging GmbH
Tegeler Strasse 6-7
13353 Berlin
Germany
Telefon: +49 30 461 124603
Fax: +49 30 461 124 629
Email: info@life-mi.com
Internet: http://www.life-mi.com

Managing Directors:
Dr. Ludger Dinkelborg
Michel Jongens

Chamber of Commerce:
Amtsgericht Charlottenburg
HRB 136823 B

Sales tax identification number:
DE 283685037

Data Protection Policy: 
https://life-mi.com/data-protection/

Biotechnology

Health Care

Life Sciences

Medical Devices

Life Molecular Imaging

Ludger Dinkelborg

Nigel Banton

Mathias Berndt

Andrew Stephens

Michel Jongens

Donna Felker

Clemens Mahnecke

Dr. Kritee Pant

Aleksandar Jovalekic

Brittany Hahn

Life Molecular Imaging

Org chart

Similar companies